A team approach to diabetes-related eye disease
Watch nowTreat & Extend in ME secondary to CRVO
Watch nowIVEG Webcast
The long-term impact of the pandemic in the management of retinal pathologies: what we have learned, what we have changed
Live pageFloretina and ICOOR Joint Meeting 2021
Watch nowExperts Arena: The Debate on Fluid Tolerance
Watch nowWhat is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Read nowBehind the mask: maintaining clear communication amid the pandemic
Watch nowCataract Surgery after lens trauma from intravitreal injections
Watch nowA video journey in the “new normal” of retina practices
Watch nowRemote monitoring with Home OCT
Watch nowA team approach to diabetes-related eye disease
To tackle diabetes-related eye diseases through a multidisciplinary team approach.
Treat & Extend in ME secondary to CRVO
In the CENTERA study, significant functional and anatomic improvements were
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?
The Debate on Fluid Tolerance
What do the studies show? What do the experts think?
What is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the
Euretina 2021 Virtual Congress
A video journey in the “new normal” of retina practices
Timely detection of wet AMD with remote home screening
Data from a retrospective real world study highlights low incidence of proactive treatment of nAMD
Remote monitoring in the management of retinal disease
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?
LEARN MOREDefining Nonadherence and Nonpersistence to Anti-VEGF Therapies in nAMD
The nAMD Barometer Leadership Coalition published a definition for nonadherence and nonpersistence to anti-VEGF.
LEARN MOREWhat is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the eyes of international thought leaders.
LEARN MOREBehind the mask: maintaining clear communication amid the pandemic
A complicated matter of doctor-patient communication during COVID-19 times.
LEARN MOREAbout us
a panel of top-tier international vitreoretinal surgeons
The experience shared by this group of professionals is aligned with their mission to promote and provide best practice recommendations
Only modern and best equipment advanced medical technologies and innovative diagnosis and treatment methods and technology.
Our organization has received a financial education grant from Bayer. Bayer has had no influence on this website content.